Search

Search Constraints

You searched for: Author/Creator Price, David E.

Search Results

1. AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations and Future Directions. Issue 5 (September 2016)

2. AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions. Issue 5 (September 2016)

4. Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UK. Issue 3 (May 2020)

6. Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic. Issue 6 (November 2018)